In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer. [electronic resource]
- Nature communications 08 2018
- 3501 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2041-1723
10.1038/s41467-018-05742-z doi
Cell Line, Tumor Female Humans Immunohistochemistry Kaplan-Meier Estimate Mass Spectrometry Phosphoproteins--metabolism Phosphotransferases--metabolism Treatment Outcome Triple Negative Breast Neoplasms--metabolism